What is Dr John Gerry Coghlan's specialty?

Dr John Gerry Coghlan is a consultant specialising in Cardiology, with extensive experience in assessing and treating patients within this field.

Which conditions and treatments does Dr John Gerry Coghlan specialise in?

Dr John Gerry Coghlan is a cardiologist who provides assessment and treatment for Hypertension (high blood pressure), Pulmonary hypertension, Angina, Shortness of breath, Interventional cardiology and Connective tissue disease. During your consultation, you will be informed of the most suitable options following a personalised evaluation.

How many years of experience does Dr John Gerry Coghlan have?

Dr John Gerry Coghlan has 42 years of professional experience as a consultant cardiologist, providing specialist assessment and treatment in this medical field.

What do patients say about Dr John Gerry Coghlan?

Patients give a rating of 5.0 out of 5 to Dr John Gerry Coghlan, a score considered excellent. This average is based on 8 verified patient reviews, reflecting the experience of those who have attended an appointment.

Are Dr John Gerry Coghlan's reviews verified?

Yes. All Dr John Gerry Coghlan's reviews come from verified patients who have attended either an in-person or an e-Consultation appointment. We use a system that ensures authenticity and prevents fake reviews. Some profiles may also display reviews from other platforms, which follow their own verification policies, with the source always clearly indicated.

Where does Dr John Gerry Coghlan practise?

Dr John Gerry Coghlan practices in the following locations: Central London at Pond Street, Hampstead. NW3 2QG North London at 60 Grove End Road In-person consultations are available at these locations as a Cardiology.

How can I book an appointment with Dr John Gerry Coghlan?

You can book an appointment with Dr John Gerry Coghlan directly from this page by selecting the time that suits you best. Alternatively, you can call the phone number shown if you prefer personalised assistance.

Does Dr John Gerry Coghlan see NHS patients?

Many specialists featured on Top Doctors also hold NHS positions. However, appointments arranged for Dr John Gerry Coghlan through this platform are private, either self-pay or covered by private medical insurance.

Does Dr John Gerry Coghlan offer private appointments?

Yes, Dr John Gerry Coghlan offers private appointments for patients seeking flexible and direct access to a consultant cardiologist.

Does Dr John Gerry Coghlan offer online consultations?

At the moment, Dr John Gerry Coghlan does not offer online consultations. You can book an in-person appointment from this page or call +44 02039703556. When calling, please mention that you are a Top Doctors patient.

Does Dr John Gerry Coghlan accept insurance?

Dr John Gerry Coghlan works with the following private medical insurance providers: Bupa, AXA, Cigna, WPA, Simply Health, Allianz, CS Healthcare, Vitality, The Exeter Friendly, Pru Health, Groupama, April, Freedom, National Assurance, General Medical, Saga, Healix, Legal & General Insurance and Health-online. If your insurer is not listed, you may contact the practice directly to confirm your coverage.

What is Dr John Gerry Coghlan's availability?

Dr John Gerry Coghlan's availability depends on the appointment slots open at any given time. On this page, you can check current availability, and if no slots are shown, you can request an appointment or contact the practice directly.

What payment methods does Dr John Gerry Coghlan offer?

You can pay for your consultation with Dr John Gerry Coghlan using the following methods: Self-paying.

What languages does Dr John Gerry Coghlan speak?

Dr John Gerry Coghlan is a cardiologist who offers consultations in English.

How is Dr John Gerry Coghlan selected to appear on this platform?

All doctors listed on Top Doctors, including Dr John Gerry Coghlan, undergo our rigorous selection process. Only one in five specialists meets the required standards to be included.

Dr John Gerry Coghlan

GMC: 2946601

5.08reviewsReview

Expert in:

Pulmonary hypertension

Interventional cardiology

Shortness of breath

Hypertension (high blood pressure)

Connective tissue disease

Angina

Professional statement

Dr John Gerry Coghlan is a leading consultant cardiologist based in London, who specialises in pulmonary hypertension and all aspects of cardiology, including complex breathlessness, arrhythmias, connective tissue disease (related to heart disease) and angina.

Dr Coghlan is an honorary senior lecturer at UCH London and a visiting consultant at Papworth Hospital Cambridge, where he performs balloon pulmonary angioplasty. He is also a visiting consultant at St Thomas' Hospital, Kings College Hospital, Royal United Hospital Bath, Queen Alexandra Hospital Portsmouth, Derriford Hospital Plymouth and Ulster Hospital Dundonald.

Dr Coghlan graduated from University College Dublin in 1983 and trained in cardiology at the National Cardiac Centre, Dublin, Harefield Hospital and The Royal Free Hospital, London. He is a founder member of the National Pulmonary Hypertension Physicians Association and developed the Royal Free National Pulmonary Hypertension Service.

He holds research interests in fields of pulmonary hypertension, cardiac imaging and ischaemic heart disease and has published over 200 papers in peer-reviewed journals. Throughout his career, he has won awards such as the Molloy prize in 1978 and a silver medal in surgery in 1983, amongst others.

Clinics

The Royal Free Hospital
Central London, Pond Street, Hampstead. NW3 2QG,
Medical insurances accepted
Bupa
AXA
Cigna
WPA
Simply Health
I'm paying for myself
Allianz
CS Healthcare

Credentials

Professional experience

42 years of experience
Consultant Cardiologist, The Royal Free Hospital NHS Trust London, (1997-present)
Consultant Cardiologist, St John & St Elizabeth's Hospital, London (present)
Visiting Consultant Cardiologist, Papworth Hospital Cambridge, St Thomas’ Hospital, Kings College Hospital, Royal United Hospital Bath, Queen Alexandra Hospital Portsmouth, Derriford Hospital Plymouth and Ulster Hospital Dundonald (present)
Senior Registrar in Cardiology, Royal Free Hospital (May 1994 - Sept 1997)
Locum Senior Registrar in Cardiology, Harefield Hospital (Mar 1994 - Apr 1994)
Registrar in Cardiology, Harefield Hospital (Mar 1992 - Feb 1994)
Research Fellow (British Heart Foundation) Brunel University Uxbridge (Mar 1990 - Feb 1992)
Registrar in Cardiology: Harefield Hospital (Jan 1988 – Feb 1990)
Registrar in Cardiology: Royal City of Dublin Hospital (University Hospital for Trinity College) (Jul 1987 – Dec 1987)
Registrar in Gastroenterology, Cardiology & General Medicine, Meath Hospital Dublin (Jul 1986 – Jun 1987)
SHO In Gastroenterology & General Medicine, Regional Hospital Galway (Jan 1986 – Jun 1986)
SHO in Respiratory & General Medicine, Regional Hospital Galway Jul (1985 – Dec 1985)
SHO in Neurology Regional Hospital Galway (Jan 1985 – Jun 1985)
Locum posts in General Medicine & General Surgery London (Jul 1984 – Dec 1984)
House Officer in Cardiac & General Surgery Mater Misercordiae Hospital Dublin (Jan 1984 &
House Officer in Cardiology & General Medicine, Mater Misercordiae Hospital Dublin (Jun 1983 - D

Subspecialties

Pulmonary hypertension
Interventional cardiology
Hypertension
Connective tissue disease (heart disease)
Angina
Angioplasty
Ischaemic heart disease
Chest pain
Cardiac imaging
Arrhythmia
ASD (Atrial septal defect)
Atherosclerosis
Atrial Fibrillation
Blood pressure test
Cardiovascular disease
Catheter
Chest pain
Cholesterol
Circulatory disorders
Coronary angiography
Coronary heart disease
Dilated cardiomyopathy
Echocardiogram
Electrocardiogram
Extrasystole
Fatty liver
Heart attack
Heart check up
Heart failure
Heart murmur
Heart problems in cancer patients (Cardio-oncology)
Heart valve replacement
Hereditary diseases
High triglycerides
Hypercholesterolemia
Hypertension
Hypertrophic Cardiomyopathy
Lipid disorders
Low blood pressure
Marfan syndrome
Metabolic syndrome
Mitral regurgitation
Myocarditis
OCT (optical coherence tomography)
Pacemaker
Palpitations
Patent foramen ovale
Pericarditis
Preventive cardiology
Second medical opinion
Stress test
Stroke
Sudden death
Supraventricular tachycardia
Syncope
Takotsubo cardiomyopathy (broken heart syndrome)
Thoracic pain
Valvular heart disease
Venous insufficiency
Ventricular tachycardia
CMR guided right heart catheterisation
Catheter-directed thrombolysis
Balloon pulmonary angioplasty
Myocardial biopsy
Invasive pulmonary angiography
Right heart catheter with vasodilator testing & fluid challenge

Professional memberships

Ex Chair of the National Pulmonary Hypertension Physicians Association (NPHPA)
Fellow of the Royal College of Physicians (FRCP)
Member of British Cardiac Society (BCS)
British Cardiovascular Intervention Society (BCIS)

Education

MD National University Ireland (1994)
MRCPI Royal College of Physicians Ireland (1985)
MB BCh BAO National University of Ireland (1983)

Teaching posts

Honorary Senior Lecturer, University College London Hospital (present)

Positions in organisations

Down’s Syndrome Association Trustee from 1999, Chairman 2006 – 2009; Deputy Chairman 2009- 2011; Chairman 2011-2014
Down’s Syndrome Medical Information Group, member from 2008
Down’s Syndrome International, member from 2011
WHO guidelines in Down's Syndrome: Steering committee & Deputy Chair Cardiology working group

Publications and conferences

Over 200 peer-reviewed publications (most recent publications at end)
Written many original articles, case reports and book chapters.
Edited Book: Cardiology in Practice by Clive Handler
Associate Editor, Pulmonary Circulation
Editor for Rheumatology, Arthritis and Rheumatism, Eur Resp J, Lupus, Arthritis & Rheumatism, Hematologia, Pulmonary Circulation, Lancet & Thorax
Editor for Remedica (2010 – 2014)
Organised many conferences both nationally and internationally
Lectured both nationally and internationally
Gräf S, Haimel M, Bleda M, H…Coghlan G, et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018 (ePub)
Coghlan JG, Wolf M, Distler O, Denton CP, Doelberg M, Harutyunova S, Marra AM, Benjamin N, Fischer C, Grünig E. Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis. Eur Respir J. 2018 (ePub)
Dawson A, Reddecliffe S, Coghlan C, Schreiber BE, Coghlan JG. Safety and feasibility audit of a home-based drug-transitioning approach for patients with pulmonary arterial hypertension: an observational study. Eur J Cardiovasc Nurs. 2018 (ePub)
Coghlan JG, Channick R, Chin K, Di Scala L, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Gaine S. Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study. Am J Cardiovasc Drugs. 2018 Feb;18(1):37-47.
Mihai C, Antic M, Dobrota R, Bonderman D, Chadha-Boreham H, Coghlan JG, Denton CP, Doelberg M, Grünig E, Khanna D, McLaughlin VV, Müller-Ladner U, Pope JE, Rosenberg DM, Seibold JR, Vonk MC, Distler O. Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort. Ann Rheum Dis. 2018 Jan;77(1):128-132
Coghlan JG, Denton C. Aggressive combination therapy for the treatment of scleroderma associated pulmonary Hypertension. JSRD 2018, Vol. 3(1) 30–38
Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, Preston SD, Southwood M, Hernandez-Sanchez J, Martin J, Treacy C, Yates K, Bogaard H, Church C, Coghlan G, Condliffe R, Corris PA, Gibbs S, Girerd B, Holden S, Humbert M, Kiely DG, Lawrie A, Machado R, MacKenzie Ross R, Moledina S, Montani D, Newnham M, Peacock A, Pepke-Zaba J, Rayner-Matthews P, Shamardina O, Soubrier F, Southgate L, Suntharalingam J, Toshner M, Trembath R, Noordegraaf AV, Wilkins MR, Wort SJ, Wharton J; NIHR BioResource–Rare Diseases Consortium; UK National Cohort Study of Idiopathic and Heritable PAH, Gräf S, Morrell NW. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension. Circulation. 2017 Nov 21;136(21):2022-2033. doi: 10.1161/CIRCULATIONAHA.117.028351. Epub 2017
Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galiè N, Ghofrani HA, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Hoeper MM. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. Eur Respir J. 2017 Aug 17;50(2). pii: 1602493. doi: 10.1183/13993003.02493-2016
Schwaiger JP, Loder CD, Dobarro D, Kaier T, Reddecliffe S, Schreiber BE, Handler C, Denton CP, Coghlan JG. Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis. Sci Rep. 2017 Feb 24;7:43304.
Coghlan JG, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, Kuwana M, McLaughlin VV, Peacock AJ, Simonneau G, Vachiéry JL, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION investigators.. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. Ann Rheum Dis. 2017 Jul;76(7):1219-1227
Humbert M, Coghlan JG, Ghofrani HA, Grimminger F, He JG, Riemekasten G, Vizza CD, Boeckenhoff A, Meier C, de Oliveira Pena J, Denton CP. Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2. Ann Rheum Dis. 2017 Feb;76(2):422-426.
Coghlan JG, Schreiber BS, D’Cruz D. The heart in rheumatic disease. Chapter 35. Hochberg’s Rheumatology 6th Edition
Gräf S, Haimel M, Bleda M, H…Coghlan G, et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018 (ePub)
Vanezis AP, Arnold JR, Rodrigo G, Lai FY, Debiec R, Nazir S, Khan JN, Ng LL, Chitkara K, CoghlanJG, Hetherington SL, McCann GP, Samani NJ. Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial. Heart. 2018 May 10. pii: heartjnl-2018-313091.
Ito Y, Carss KJ, Duarte ST, et al; NIHR BioResource (Coghlan G); Care4Rare Canada Consortium, Boycott KM, Kernohan KD, Dyack S, Raymond FL. De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures. Am J Hum Genet. 2018 Jul 5;103(1):144-153.
Hobbs AJ, Moyes AJ, Baliga RS, Ghedia D, Ochiel R, Sylvestre Y, Doré CJ, Chowdhury K, Maclagan K, Quartly HL, Sofat R, Smit A, Schreiber BE, Coghlan GJ, MacAllister RJ. Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Br J Pharmacol. 2019 May;176(9):1251-1267
Sofianopoulou E, Kaptoge S, Gräf S, .. Coghlan G, … Morrell NW. Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: A United Kingdom cohort study analysis. Eur Respir J. 2019 Mar 28. pii: 1801429.
Bunclark K, Newnham M, Chiu YD, Ruggiero A, Villar SS, Cannon JE, Coghlan G, Corris PA, Howard L, Jenkins D, Johnson M, Kiely DG, Ng C, Screaton N, Sheares K, Taboada D, Tsui S, Wort SJ, Pepke-Zaba J, Toshner M. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2019 Sep 26. doi: 10.1111/jth.14649
Pan Z, Marra AM, Benjamin N, Eichstaedt CA, Blank N, Bossone E, Cittadini A, Coghlan G, Denton CP, Distler O, Egenlauf B, Fischer C, Harutyunova S, Xanthouli P, Lorenz HM, Grünig E. Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study). Arthritis Res Ther. 2019 Oct 26;21(1):217. doi: 10.1186/s13075-019-1981-0.
Hodgson J, Swietlik EM, Salmon RM, … Coghlan G, … Morrell NW. Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2019 Oct 29. doi: 10.1164/rccm.201906-1141OC.
McLaughlin VV, Channick R, De Marco T, Farber HW, Gaine S, Galié N, Krasuski RA, Preston I, Souza R, Coghlan JG, Frantz RP, Hemnes A, Kim NH, Lang IM, Langleben D, Li M, Sitbon O, Tapson V, Frost A. Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents. Chest. 2019 Nov 16. pii: S0012-3692(19)34214-X.
Kirresh A, Coghlan G, Candilio L. COVID-19 infection and high intracoronary thrombus burden. Cardiovasc Revasc Med. 2020 Jul 30:S1553-8389(20)30459-0. doi: 10.1016/j.carrev.2020.07.032
Hoeper MM, Pausch C, Grünig E, ..., Coghlan G, ... Held M. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry. J Heart Lung Transplant. 2020 Sep 30:S1053-2498(20)31758-7. doi: 10.1016/j.healun.2020.09.011.
Sofianopoulou E, Church C, Coghlan G, et al. Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease? Eur Respir J. 2020 Aug 13;56(2):1902334. doi: 10.1183/13993003.02334-2019
Hodgson J, Swietlik EM, Salmon RM, ... Coghlan G, ... Morrell NW. Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020 Mar 1;201(5):575-585.
Bunclark K, Newnham M, Chiu YD, ... Coghlan G, ... Toshner M. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020 Jan;18(1):114-122.
Lewis RA, Armstrong I, Bergbaum C, ...Coghlan JG, ...Toshner MR, Wanjiku I, Wort SJ, Yorke J, Condliffe R. EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease- associated pulmonary arterial hypertension: results from a UK multi-centre study. Eur Respir J. 2020 Jul 6:2000124.
Rhodes CJ, Otero-Núñez P, Wharton J, S...Coghlan JG, ... Wilkins MR. Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome. Am J Respir Crit Care Med. 2020 Aug 15;202(4):586-594.
Peacock AJ, Ling Y, Johnson MK, Kiely DG, ... Coghlan JG, ..., Gatzoulis MA. Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? Pulm Circ. 2020 Mar 30;10(1):2045894020914851
Hoole SP, Coghlan JG, Cannon JE, et al. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience. Open Heart. 2020 Feb 27;7(1):e001144. doi: 10.1136/openhrt-2019-001144.
Kuwana M, Blair C, Takahashi T, Langley J, Coghlan JG. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. Ann Rheum Dis. 2020 May;79(5):626-634. doi: 10.1136/annrheumdis-2019-216274.
Coghlan JG, Picken C, Clapp LH. Selexipag in the management of pulmonary arterial hypertension: an update. Drug Healthc Patient Saf. 2019 Aug 6;11:55-64.

Prizes and awards

Silver Medal in Surgery, Mater Misericordiae Hospital, Dublin (1983)
Prize in Paediatrics, Our Lady’s Hospital Crumlin (1982)
University College Dublin Prize, Third Medicine (1981)
MMH Scholarship, Third Medicine (1981)
University College Dublin Prize, Second Medicine (1980)
University College Dublin Scholarship, First Medicine Catholic University Scholarship (1979)
Molloy Prize in Chemistry (1978)

Languages spoken

English

Registration number: 2946601

Reviews

All reviews are from real patients and have been verified by our Customer Service department to ensure they meet our guidelines. Rules of the service

8 reviews

5.0

Review this doctor

Would you recommend this doctor?
Treatment of the doctor
Treatment of the staff
Waiting time
Condition of facilities

2 September 2020
J.S.
Verified patient
2 September 2020
J.S.
Verified patient
2 September 2020
C.G.
Verified patient
2 September 2020
C.G.
Verified patient
Yes, I would. Good explanations and interested.
17 March 2020
M.A.
Verified patient
Yes, I would. Good explanations and interested.
17 March 2020
M.A.
Verified patient
12 November 2018
L.H.
Verified patient
12 November 2018
L.H.
Verified patient

Treatments

The doctor is expert in

Angina

Connective tissue disease

Hypertension (high blood pressure)

Interventional cardiology

Pulmonary hypertension

Shortness of breath

The doctor also specialises in:

Arrhythmia

Atherosclerosis

Atrial Fibrillation

Atrial septal defect

Blood pressure test

Cardio-oncology

Cardiovascular disease

Catheter

Chest pain

Cholesterol

Frequently Asked Questions

The doctor, or where applicable the hospital or medical centre in which the doctor provides services, undertakes to keep the information relating to the prices of services published on their profile on the Top Doctors platform up to date at all times, ensuring that such prices correspond to those effectively charged to patients. In the event of any discrepancy between the published price and the price ultimately charged to the patient, the doctor and/or the relevant hospital or medical centre shall be solely liable towards the patient and towards Top Doctors for any claim or financial difference arising therefrom.

Dr John Gerry Coghlan

Cardiology in Central London and North London

Professional statement

Clinics

The Royal Free Hospital

Credentials

Professional experience

Subspecialties

Professional memberships

Education

Teaching posts

Positions in organisations

Publications and conferences

Prizes and awards

Languages spoken

Reviews

Treatments

The doctor is expert in

Frequently Asked Questions

What is Dr John Gerry Coghlan's specialty?

Which conditions and treatments does Dr John Gerry Coghlan specialise in?

How many years of experience does Dr John Gerry Coghlan have?

What do patients say about Dr John Gerry Coghlan?

Are Dr John Gerry Coghlan's reviews verified?

Where does Dr John Gerry Coghlan practise?

How can I book an appointment with Dr John Gerry Coghlan?

Does Dr John Gerry Coghlan see NHS patients?

Does Dr John Gerry Coghlan offer private appointments?

Does Dr John Gerry Coghlan offer online consultations?

Does Dr John Gerry Coghlan accept insurance?

What is Dr John Gerry Coghlan's availability?

What payment methods does Dr John Gerry Coghlan offer?

What languages does Dr John Gerry Coghlan speak?

How is Dr John Gerry Coghlan selected to appear on this platform?